FDA discourages use of laparoscopic power morcellation for removal of uterus or uterine fibroids

In a safety communication notice issued today, the U.S. Food and Drug Administration discouraged the use of laparoscopic power morcellation for the removal of the uterus (hysterectomy) or uterine fibroids (myomectomy) in women because, based on an analysis of currently available data, it poses a risk of spreading unsuspected cancerous tissue, notably uterine sarcomas, beyond the uterus.
Source: Food and Drug Administration - Category: American Health Source Type: news